Talecris Biotherapeutics.

PositionAcquisitions - Brief Article

RESEARCH TRIANGLE PARK -- Talecris Biotherapeutics, a new company based here and backed by New York-based Cerberus Capital Management and Wellesley, Mass.-based Ampersand Ventures, bought Bayer's plasma-products business for $590 million. About 1,600 of Talecris' 1,700...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT